Sysmex Establishes Subsidiary in Saudi Arabia
An economic powerhouse in the Middle East, Saudi Arabia is experiencing population growth and stable economic development. As its demand for an enhancement of medical infrastructure surges, its healthcare market is expected to expand further. In its Vision 2030, the Saudi Arabian government has made clear its intention to break away from oil dependence. One of the programs to diversify its economy is to accelerate the development of the healthcare field.
Since the establishment in 2008 of a subsidiary in Dubai, the United Arab Emirates, Sysmex has supported local distributors and organized scientific awareness activities in the Middle East and Northeast Africa. The subsequent establishment of a subsidiary in Egypt in 2018 increased the drive to reinforce our sales and service structure in the Middle East region.
In a bid to forge a solid business foundation in Saudi Arabia, which promises high market growth in the region, Sysmex has established a new subsidiary, leaving behind sales and services via local distributors to conduct direct sales and services.
Going forward, by capturing customer needs with precision, Sysmex aims to gain a greater market share for its mainstay hematology business in the region, while at the same time creating a stronghold in the urinalysis and hemostasis markets there and seeking opportunities for other businesses.
Sysmex has identified "Responsible provision of products and services" as one of its priority issues (materiality), and is working to reinforce our sales, service, and support structure on a global basis. Through the provision of a broad line of products and customized services and support, we continue to bring greater trust and confidence to our valued stakeholders.
Biotech & Pharma
Eppendorf divests micro manipulation product portfolio
Biotech & Pharma, Research, Academia & Universities